PAI-1 is widely expressed in skin cancers, and it may act on multiple levels as an anti-fibrinolytic and a modulator of ECM and MMPs underlying tumor microenvironment remodeling and melanoma invasion [58]. Here, SERPINE1 is linked to melanoma.